ID   DAPK3_HUMAN             Reviewed;         454 AA.
AC   O43293; A0AVN4; B3KQE2;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   05-OCT-2010, entry version 96.
DE   RecName: Full=Death-associated protein kinase 3;
DE            Short=DAP kinase 3;
DE            EC=2.7.11.1;
DE   AltName: Full=DAP-like kinase;
DE            Short=Dlk;
DE   AltName: Full=ZIP-kinase;
GN   Name=DAPK3; Synonyms=ZIPK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=98147805; PubMed=9488481;
RA   Kawai T., Matsumoto M., Takeda K., Sanjo H., Akira S.;
RT   "ZIP kinase, a novel serine/threonine kinase which mediates
RT   apoptosis.";
RL   Mol. Cell. Biol. 18:1642-1651(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Cervix carcinoma;
RX   MEDLINE=99283879; PubMed=10356987; DOI=10.1016/S0014-5793(99)00550-5;
RA   Murata-Hori M., Suizu F., Iwasaki T., Kikuchi A., Hosoya H.;
RT   "ZIP kinase identified as a novel myosin regulatory light chain kinase
RT   in HeLa cells.";
RL   FEBS Lett. 451:81-84(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH DAXX AND PAWR.
RX   MEDLINE=22799111; PubMed=12917339;
RX   DOI=10.1128/MCB.23.17.6174-6186.2003;
RA   Kawai T., Akira S., Reed J.C.;
RT   "ZIP kinase triggers apoptosis from nuclear PML oncogenic domains.";
RL   Mol. Cell. Biol. 23:6174-6186(2003).
RN   [6]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12560483; DOI=10.1093/nar/gkg176;
RA   Preuss U., Landsberg G., Scheidtmann K.H.;
RT   "Novel mitosis-specific phosphorylation of histone H3 at Thr11
RT   mediated by Dlk/ZIP kinase.";
RL   Nucleic Acids Res. 31:878-885(2003).
RN   [7]
RP   FUNCTION, ENZYME REGULATION, AUTOPHOSPHORYLATION, PHOSPHORYLATION AT
RP   THR-180; THR-265 AND THR-299, AND MUTAGENESIS OF LYS-42; ASP-161;
RP   THR-225; THR-265 AND THR-299.
RX   PubMed=17158456; DOI=10.1074/jbc.M609990200;
RA   Hagerty L., Weitzel D.H., Chambers J., Fortner C.N., Brush M.H.,
RA   Loiselle D., Hosoya H., Haystead T.A.;
RT   "ROCK1 phosphorylates and activates zipper-interacting protein
RT   kinase.";
RL   J. Biol. Chem. 282:4884-4893(2007).
RN   [8]
RP   INTERACTION WITH UBE2D1; UBE2D2 AND UBE2D3, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=18515077; DOI=10.1016/j.bbrc.2008.05.113;
RA   Ohbayashi N., Okada K., Kawakami S., Togi S., Sato N., Ikeda O.,
RA   Kamitani S., Muromoto R., Sekine Y., Kawai T., Akira S., Matsuda T.;
RT   "Physical and functional interactions between ZIP kinase and UbcH5.";
RL   Biochem. Biophys. Res. Commun. 372:708-712(2008).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 1-277.
RA   Kursula P., Vahokoski J., Wilmanns M.;
RT   "Crystal structure of human ZIP kinase.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [10]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-112; ASN-161 AND SER-216.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine kinase which acts as a positive
CC       regulator of apoptosis. Phosphorylates histone H3 on 'Thr-11' at
CC       centromeres during mitosis. Regulates myosin light chain
CC       phosphatase through phosphorylation of MYPT1 thereby regulating
CC       the assembly of the actin cytoskeleton, cell migration,
CC       invasiveness of tumor cells, smooth muscle contraction and neurite
CC       outgrowth. Involved in the formation of promyelocytic leukemia
CC       protein nuclear body (PML-NB), one of many subnuclear domains in
CC       the eukaryotic cell nucleus, and which is involved in oncogenesis
CC       and viral infection.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Phosphorylated on Thr-265 and Thr-299 by ROCK1
CC       which activates the kinase.
CC   -!- SUBUNIT: Homodimer or forms heterodimers with ATF4. Both
CC       interactions require an intact leucine zipper domain and
CC       oligomerization is required for full enzymatic activity. Also
CC       binds to DAXX and PAWR, possibly in a ternary complex which plays
CC       a role in caspase activation. Interacts with AATF, CDC5L, UBE2D1,
CC       UBE2D2 AND UBE2D3.
CC   -!- INTERACTION:
CC       Q9UER7:DAXX; NbExp=1; IntAct=EBI-77293, EBI-77321;
CC       O35613:Daxx (xeno); NbExp=1; IntAct=EBI-77293, EBI-77304;
CC       Q96IZ0:PAWR; NbExp=1; IntAct=EBI-77293, EBI-595869;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm (By similarity). Nucleus,
CC       PML body. Note=Relocates to the cytoplasm on binding PAWR where
CC       the complex appears to interact with actin filaments (By
CC       similarity). Localizes to promyelocytic leukemia protein nuclear
CC       bodies (PML-NBs). Associates to centromeres from prophase to
CC       anaphase.
CC   -!- PTM: Ubiquitinated. Ubiquitination mediated by the UBE2D3 E3
CC       ligase does not lead to proteasomal degradation, but influences
CC       promyelocytic leukemia protein nuclear bodies (PML-NBs) formation
CC       in the nucleus.
CC   -!- PTM: Autophosphorylated. Phosphorylated by ROCK1.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. DAP kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB007144; BAA24955.1; -; mRNA.
DR   EMBL; AB022341; BAA81746.1; -; mRNA.
DR   EMBL; AK074799; BAG52004.1; -; mRNA.
DR   EMBL; BC126430; AAI26431.1; -; mRNA.
DR   EMBL; BC126432; AAI26433.1; -; mRNA.
DR   IPI; IPI00015213; -.
DR   RefSeq; NP_001339.1; -.
DR   UniGene; Hs.631844; -.
DR   PDB; 1YRP; X-ray; 3.10 A; A/B=1-277.
DR   PDB; 2J90; X-ray; 2.00 A; A/B=9-289.
DR   PDB; 3BHY; X-ray; 1.24 A; A=9-289.
DR   PDB; 3BQR; X-ray; 1.75 A; A=9-289.
DR   PDBsum; 1YRP; -.
DR   PDBsum; 2J90; -.
DR   PDBsum; 3BHY; -.
DR   PDBsum; 3BQR; -.
DR   ProteinModelPortal; O43293; -.
DR   IntAct; O43293; 4.
DR   MINT; MINT-6505325; -.
DR   STRING; O43293; -.
DR   PhosphoSite; O43293; -.
DR   PRIDE; O43293; -.
DR   Ensembl; ENST00000301264; ENSP00000301264; ENSG00000167657.
DR   GeneID; 1613; -.
DR   KEGG; hsa:1613; -.
DR   UCSC; uc002lzc.1; human.
DR   CTD; 1613; -.
DR   GeneCards; GC19M003909; -.
DR   H-InvDB; HIX0014650; -.
DR   HGNC; HGNC:2676; DAPK3.
DR   MIM; 603289; gene.
DR   PharmGKB; PA27144; -.
DR   eggNOG; prNOG16328; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG101549; -.
DR   InParanoid; O43293; -.
DR   OMA; NFERFSK; -.
DR   OrthoDB; EOG9ZW7WM; -.
DR   PhylomeDB; O43293; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Reactome; REACT_578; Apoptosis.
DR   NextBio; 6630; -.
DR   ArrayExpress; O43293; -.
DR   Bgee; O43293; -.
DR   CleanEx; HS_DAPK3; -.
DR   Genevestigator; O43293; -.
DR   GermOnline; ENSG00000167657; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0043522; F:leucine zipper domain binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0016568; P:chromatin modification; IEA:UniProtKB-KW.
DR   GO; GO:0006917; P:induction of apoptosis; IDA:UniProtKB.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR020676; Death-assoc_prot_kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR020675; Myosin_light_chain_kin-rel.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22964:SF1; Death-assoc_prot_kinase; 1.
DR   PANTHER; PTHR22964; Myosin_light_chain_kin-rel; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; ATP-binding; Chromatin regulator;
KW   Complete proteome; Cytoplasm; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase; Ubl conjugation.
FT   CHAIN         1    454       Death-associated protein kinase 3.
FT                                /FTId=PRO_0000085914.
FT   DOMAIN       13    275       Protein kinase.
FT   NP_BIND      19     27       ATP (By similarity).
FT   REGION      395    454       Interaction with CDC5L (By similarity).
FT   ACT_SITE    139    139       Proton acceptor (By similarity).
FT   BINDING      42     42       ATP (Probable).
FT   MOD_RES     180    180       Phosphothreonine.
FT   MOD_RES     265    265       Phosphothreonine; by ROCK1.
FT   MOD_RES     299    299       Phosphothreonine; by ROCK1.
FT   VARIANT     112    112       T -> M (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040438.
FT   VARIANT     161    161       D -> N (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040439.
FT   VARIANT     216    216       P -> S (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_040440.
FT   MUTAGEN      42     42       K->A: Loss of kinase activity at low
FT                                concentrations of ATP.
FT   MUTAGEN     161    161       D->A: Loss of kinase activity.
FT   MUTAGEN     225    225       T->A: Loss of kinase activity.
FT   MUTAGEN     265    265       T->A: Loss of phosphorylation by ROCK1,
FT                                catalytically inactive.
FT   MUTAGEN     299    299       T->A: Loss of phosphorylation by ROCK1.
FT   HELIX         9     12
FT   STRAND       13     21
FT   STRAND       23     32
FT   TURN         33     35
FT   STRAND       38     46
FT   STRAND       53     56
FT   HELIX        58     70
FT   STRAND       79     84
FT   STRAND       86     94
FT   HELIX       101    108
FT   HELIX       113    132
FT   HELIX       142    144
FT   STRAND      145    148
FT   STRAND      150    154
FT   STRAND      157    159
FT   HELIX       181    183
FT   HELIX       186    189
FT   HELIX       197    212
FT   HELIX       222    230
FT   HELIX       238    241
FT   HELIX       246    253
FT   HELIX       260    262
FT   HELIX       266    271
FT   HELIX       273    280
SQ   SEQUENCE   454 AA;  52536 MW;  56773008A6A61CF0 CRC64;
     MSTFRQEDVE DHYEMGEELG SGQFAIVRKC RQKGTGKEYA AKFIKKRRLS SSRRGVSREE
     IEREVNILRE IRHPNIITLH DIFENKTDVV LILELVSGGE LFDFLAEKES LTEDEATQFL
     KQILDGVHYL HSKRIAHFDL KPENIMLLDK NVPNPRIKLI DFGIAHKIEA GNEFKNIFGT
     PEFVAPEIVN YEPLGLEADM WSIGVITYIL LSGASPFLGE TKQETLTNIS AVNYDFDEEY
     FSNTSELAKD FIRRLLVKDP KRRMTIAQSL EHSWIKAIRR RNVRGEDSGR KPERRRLKTT
     RLKEYTIKSH SSLPPNNSYA DFERFSKVLE EAAAAEEGLR ELQRSRRLCH EDVEALAAIY
     EEKEAWYREE SDSLGQDLRR LRQELLKTEA LKRQAQEEAK GALLGTSGLK RRFSRLENRY
     EALAKQVASE MRFVQDLVRA LEQEKLQGVE CGLR
//
